EDGAR Filing Documents for 0001493152-21-009619

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

SEC Accession No. 0001493152-21-009619

Filing Date

2021-04-26

Accepted

2021-04-26 06:31:16

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		forms-1a.htm	S-1/A	1816766
2		ex5-1.htm	EX-5.1	30401
3		ex23-1.htm	EX-23.1	3638
4		s-1_001.jpg	GRAPHIC	7111
5		img_005.jpg	GRAPHIC	122365
6		img_006.jpg	GRAPHIC	38429
7		img_003.jpg	GRAPHIC	20507
8		img_004.jpg	GRAPHIC	17302
9		ex5-1_001.jpg	GRAPHIC	4789
10		ex5-1_002.jpg	GRAPHIC	2224
	Complete submission text file	0001493152-21-009619.txt		5247228

Data Files

Seq	Description	Document	Type	Size
11	XBRL INSTANCE FILE	ptix-20201231.xml	EX-101.INS	600761
12	XBRL SCHEMA FILE	ptix-20201231.xsd	EX-101.SCH	44036
13	XBRL CALCULATION FILE	ptix-20201231_cal.xml	EX-101.CAL	52917
14	XBRL DEFINITION FILE	ptix-20201231_def.xml	EX-101.DEF	201817
15	XBRL LABEL FILE	ptix-20201231_lab.xml	EX-101.LAB	346154
16	XBRL PRESENTATION FILE	ptix-20201231_pre.xml	EX-101.PRE	279764

Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010

Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200

Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)